162 related articles for article (PubMed ID: 22706573)
1. Expression of gremlin 1 correlates with increased angiogenesis and progression-free survival in patients with pancreatic neuroendocrine tumors.
Chen MH; Yeh YC; Shyr YM; Jan YH; Chao Y; Li CP; Wang SE; Tzeng CH; Chang PM; Liu CY; Chen MH; Hsiao M; Huang CY
J Gastroenterol; 2013 Jan; 48(1):101-8. PubMed ID: 22706573
[TBL] [Abstract][Full Text] [Related]
2. Expression of Sex Determining Region Y-Box 2 and Pancreatic and Duodenal Homeobox 1 in Pancreatic Neuroendocrine Tumors.
Akiyama T; Shida T; Yoshitomi H; Takano S; Kagawa S; Shimizu H; Ohtsuka M; Kato A; Furukawa K; Miyazaki M
Pancreas; 2016 Apr; 45(4):522-7. PubMed ID: 26491904
[TBL] [Abstract][Full Text] [Related]
3. The clinicopathological significance of angiogenesis in hindgut neuroendocrine tumors obtained via an endoscopic procedure.
Okubo Y; Motohashi O; Nakayama N; Nishimura K; Kasajima R; Miyagi Y; Shiozawa M; Yoshioka E; Suzuki M; Washimi K; Kawachi K; Nito M; Kameda Y; Yokose T
Diagn Pathol; 2016 Nov; 11(1):128. PubMed ID: 27821179
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical analysis of OTP and NKX6.1 in neuroendocrine tumors of the lung and pancreas.
Yoxtheimer LM; Heymann JJ; Cohen C; Rao RA; Goyal A; Siddiqui MT
Diagn Cytopathol; 2018 Dec; 46(12):1010-1014. PubMed ID: 30284410
[TBL] [Abstract][Full Text] [Related]
5. Microvascular density does not correlate with histopathology and outcome in neuroendocrine tumors of the pancreas.
Tan G; Cioc AM; Perez-Montiel D; Ellison EC; Frankel WL
Appl Immunohistochem Mol Morphol; 2004 Mar; 12(1):31-5. PubMed ID: 15163016
[TBL] [Abstract][Full Text] [Related]
6. An expression signature of the angiogenic response in gastrointestinal neuroendocrine tumours: correlation with tumour phenotype and survival outcomes.
Pinato DJ; Tan TM; Toussi ST; Ramachandran R; Martin N; Meeran K; Ngo N; Dina R; Sharma R
Br J Cancer; 2014 Jan; 110(1):115-22. PubMed ID: 24231952
[TBL] [Abstract][Full Text] [Related]
7. Comparison of functional and nonfunctional neuroendocrine tumors in the pancreas and peripancreatic region.
Wang SE; Su CH; Kuo YJ; Shyr YM; Li AF; Chen TH; Wu CW; Lee CH
Pancreas; 2011 Mar; 40(2):253-9. PubMed ID: 20966805
[TBL] [Abstract][Full Text] [Related]
8. HSP90 expression and early recurrence in gastroenteropancreatic neuroendocrine tumors: Potential for a novel therapeutic target.
Gamboa AC; Ethun CG; Postlewait LM; Lopez-Aguiar AG; Zhelnin K; Krasinskas A; El-Rayes BF; Russell MC; Kooby DA; Staley CA; Cardona K; Maithel SK
Surg Oncol; 2020 Dec; 35():460-465. PubMed ID: 33080545
[TBL] [Abstract][Full Text] [Related]
9. VEGF and Id-1 in pancreatic adenocarcinoma: prognostic significance and impact on angiogenesis.
Georgiadou D; Sergentanis TN; Sakellariou S; Filippakis GM; Zagouri F; Vlachodimitropoulos D; Psaltopoulou T; Lazaris AC; Patsouris E; Zografos GC
Eur J Surg Oncol; 2014 Oct; 40(10):1331-7. PubMed ID: 24480377
[TBL] [Abstract][Full Text] [Related]
10. Endocan expression is correlated with poor progression-free survival in patients with pancreatic neuroendocrine tumors.
Lin LY; Yeh YC; Chu CH; Won JGS; Shyr YM; Chao Y; Li CP; Wang SE; Chen MH
Medicine (Baltimore); 2017 Oct; 96(41):e8262. PubMed ID: 29019897
[TBL] [Abstract][Full Text] [Related]
11. Angiogenesis and cathepsin expression are prognostic factors in pancreatic adenocarcinoma after curative resection.
Niedergethmann M; Hildenbrand R; Wolf G; Verbeke CS; Richter A; Post S
Int J Pancreatol; 2000 Aug; 28(1):31-9. PubMed ID: 11185708
[TBL] [Abstract][Full Text] [Related]
12. A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.
Tang LH; Basturk O; Sue JJ; Klimstra DS
Am J Surg Pathol; 2016 Sep; 40(9):1192-202. PubMed ID: 27259015
[TBL] [Abstract][Full Text] [Related]
13. Gremlin is a key pro-fibrogenic factor in chronic pancreatitis.
Staloch D; Gao X; Liu K; Xu M; Feng X; Aronson JF; Falzon M; Greeley GH; Rastellini C; Chao C; Hellmich MR; Cao Y; Ko TC
J Mol Med (Berl); 2015 Oct; 93(10):1085-1093. PubMed ID: 26141517
[TBL] [Abstract][Full Text] [Related]
14. High KIT and PDGFRA are associated with shorter patients survival in gastroenteropancreatic neuroendocrine tumors, but mutations are a rare event.
Knösel T; Chen Y; Altendorf-Hofmann A; Danielczok C; Freesmeyer M; Settmacher U; Wurst C; Schulz S; Yang LL; Petersen I
J Cancer Res Clin Oncol; 2012 Mar; 138(3):397-403. PubMed ID: 22160160
[TBL] [Abstract][Full Text] [Related]
15. Hormonally defined pancreatic and duodenal neuroendocrine tumors differ in their transcription factor signatures: expression of ISL1, PDX1, NGN3, and CDX2.
Hermann G; Konukiewitz B; Schmitt A; Perren A; Klöppel G
Virchows Arch; 2011 Aug; 459(2):147-54. PubMed ID: 21739268
[TBL] [Abstract][Full Text] [Related]
16. Angiogenesis: a prognostic determinant in pancreatic cancer?
van der Zee JA; van Eijck CH; Hop WC; van Dekken H; Dicheva BM; Seynhaeve AL; Koning GA; Eggermont AM; ten Hagen TL
Eur J Cancer; 2011 Nov; 47(17):2576-84. PubMed ID: 21958461
[TBL] [Abstract][Full Text] [Related]
17. Association between immunohistochemical expression of vascular endothelial growth factor (VEGF), VEGF-expressing neuroendocrine-differentiated tumor cells, and outcome in prostate cancer patients subjected to watchful waiting.
Borre M; Nerstrøm B; Overgaard J
Clin Cancer Res; 2000 May; 6(5):1882-90. PubMed ID: 10815911
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of ATM and cyclin B1 in pancreatic neuroendocrine tumor.
Shin JU; Lee CH; Lee KT; Lee JK; Lee KH; Kim KM; Kim KM; Park SM; Rhee JC
Tumour Biol; 2012 Oct; 33(5):1645-51. PubMed ID: 22707287
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic Neuroendocrine Tumors.
Salaria SN; Shi C
Surg Pathol Clin; 2016 Dec; 9(4):595-617. PubMed ID: 27926362
[TBL] [Abstract][Full Text] [Related]
20. Microvessel Landscape Assessment in Pancreatic Ductal Adenocarcinoma: Unclear Value of Targeting Endoglin (CD105) as Prognostic Factor of Clinical Outcome.
Lytras D; Leontara V; Kefala M; Foukas PG; Giannakou N; Pouliakis A; Dervenis C; Panayiotides IG; Karakitsos P
Pancreas; 2015 Jan; 44(1):87-92. PubMed ID: 25058886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
